Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 161 of the 162 references it cites were found in a registry or an index.

The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis

Hirschfield, Gideon M., Gershwin, M. Eric · 2013 · Annual Review of Pathology: Mechanisms of Disease

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune disease characterized by clinical homogeneity among patients, an overwhelming female predominance, production of a multilineage immune response to mitochondrial autoantigens, inflammation of small bile ducts, and in some patients the development of fibrosis and cirrhosis. The targets in this disease are small bile ducts, and the prototypic serologic response includes antimitochondrial antibodies (AMAs). Several key observations have greatly advanced our understanding of PBC. First, the multilineage immune response, including AMAs, is directed at the E2 component of the 2-oxo-dehydrogenase pathway, particularly PDC-E2. Second, such autoantibodies may be identified years before the clinical diagnosis of disease. Third, the autoreactive T cell precursor frequency for both CD4 and CD8 cells is significantly higher in liver and regional lymph node than in blood, so the multilineage antimitochondrial response may be required for the development of this disease. Fourth, the apotope of biliary cells contains intact PDC-E2; this apotope, in a setting that includes granulocyte macrophage colony–stimulating factor–stimulated macrophages and AMAs, produces an intense proinflammatory response. Fifth, several mouse models of PBC highlight the importance of loss of tolerance to PDC-E2 as well as a critical role for the interleukin (IL)-12 signaling pathway. Finally, genome-wide association studies suggest an important role for the IL-12 pathway in disease susceptibility. Taken together, these findings have resulted in a better understanding of the mechanism for selective biliary cell destruction and have also suggested unique pathways for therapeutic intervention.

Overview

Integrity signals

Registry

Crossref · 10.1146/annurev-pathol-020712-164014

Cites

161 of 161 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 162 references

Research works printed but not linked: 5

  1. Tsuneyama K, 1995, Hepatology, 21, 1031
  2. Tsuneyama K, 1995, Hepatology, 22, 1440
  3. 10.1053/j.gastro.2011.02.044 · DOI
  4. Arenas F, 2008, J. Clin. Investig., 118, 695
  5. 10.1002/hep.510240517 · doi:10.1002/hep.510240517

Cited by

See all 341

Metadata

Authors
Hirschfield, G. M., & Gershwin, M. E.
Affiliations
  • University of Birmingham (GB)
  • University of California, Davis (US)
Venue
Annual Review of Pathology: Mechanisms of Disease
Published
2013-01-24
Volume
8
Issue
1
Pages
303-330
ISSN
  • 1553-4006 (ISSN-L)
  • 1553-4014
OpenAlex
W2152758419
Cited by
315
References
162
Citations by year
2026: 13 · 2025: 18 · 2024: 13 · 2023: 24 · 2022: 13 · 2021: 21 · 2020: 31 · 2019: 21 · 2018: 31 · 2017: 25 · 2016: 16 · 2015: 49 · 2014: 31 · 2013: 6
FWCI
4.32
Type
journal article
Language
en
Open access
closed
Locations
  • Annual Review of Pathology Mechanisms of Disease (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
  • Wellcome Trust
  • National Institutes of Health
  • Canadian Institutes of Health Research (MOP74621)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 39588)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary biliary cirrhosis, autoimmune disease, antimitochondrial antibodies, PDC-E2, mitochondrial autoantigens, bile duct inflammation, autoreactive T cells, loss of tolerance, macrophages, mouse model, disease susceptibility, fibrosis, female predominance
MeSH terms
Amino Acid Sequence, Animals, Autoantibodies, Autoantigens, Bile Ducts, Humans, Liver, Liver Cirrhosis, Biliary, Molecular Sequence Data, CD8-Positive T-Lymphocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis. https://app.cochat.ai/papers/10.1146/annurev-pathol-020712-164014
The paper
Hirschfield, G. M., & Gershwin, M. E. (2013). The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis. Annual Review of Pathology: Mechanisms of Disease. https://doi.org/10.1146/annurev-pathol-020712-164014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.